Annual Drug Patent Expirations for ZETIA
Zetia is a drug marketed by Organon and is included in one NDA. There are two patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for ZETIA.
The generic ingredient in ZETIA is ezetimibe. Additional details are available on the ezetimibe profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com